Everest Organics Chart
Everest Organics Share Key Metrics
Volume
1098.00
Market Cap
274.76 CR
LTQ@LTP
13@275.00
ATP
272.29
Var Margin
29.79 %
Circuit Range
226.4-339.5
Delivery %
0 %
Value
2.99 L
ASM/GSM
No
Market Lot
1
Summary
Everest Organics Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
59.54
Sector P/B
2.65
Sec. Div. Yield
0.59
Everest Organics Resistance and Support
Pivot 284.07
Resistance
First Resistance
288.14
Second Resistance
293.32
Third Resistance
297.39
Support
First Support
278.89
Second Support
274.82
Third Support
269.64
Everest Organics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-27 | Quarterly Results |
| 2025-02-11 | Quarterly Results |
| 2025-01-13 | Others |
Everest Organics News
Everest Organics Ltd - 524790 - Disclosure Of Reasons For Delay In Submission Of Financial Results For The Quarter Ended December 31, 2025 Under Regulation 33 Of SEBI (LODR) Regulations, 2015
Everest Organics Ltd explained the delay in submitting Q3 FY26 financial results for quarter ended December 31, 2025. The delay was due to detailed board discussions and additional information needed for finalization, leading to a missed 45-day deadline.
Mar 06 2026 12:03:00
Everest Organics Ltd - 524790 - Board Meeting Outcome for Outcome Of Board Meeting Dated February 14, 2026 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025
Everest Organics reported Q3 FY26 net profit of ₹0.35 cr on revenue of ₹42.59 cr. Auditors issued significant qualifications, including operating without environmental approvals and an unprovided supplier interest liability of ₹1.43 cr for the nine months period.
Feb 15 2026 01:02:00
About Everest Organics
NSE : 0
BSE : 524790
ISIN : INE334C01029
Everest Organics Limited a company with its registeredoffice at Hyderabad was incorporated on 19th February1993. The company has subsequently obtained the certificateof commencement of business on 17th March 1993. Thefactory of the company is situated at Aroor VillageSadasivpet Mandal Medak district A.P. The unit iseligible for incentives like State Subsidy Sales Taxdeferment and Power Tariff etc. as the unit is beinglocated in Notified Backward Area. The main objects of thecompany is to carry on the business of manufacturingselling of bulk drugs and formulations which are fully setout in its Memorandum and Articles of Association and arealso mentioned below in this prospectus.M/s Everest Organics Limited envisages to set up a projectwith a total outlay of Rs.1850 lakhs for Manufacturing BulkDrugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totallyan Import substitute) Omeprazole Ciprofloxacin at AroorVillage Sadasivpet Mandal Medak district A.P. As per theschedule given in the project appraisal the plant will gointo Commercial Production by the end of September 1995.However the management is confident of implementing theproject ahead of the timeframe given in the implementationschedule and starting Commercial Production by July 1995i.e.; 2 months ahead of schedule.
Everest Organics Management
| Name | Position |
|---|---|
| Mr. Prasad Venkata Satya Sundara Srikakolapu | Chairman & Ind.Director |
| Dr. Sri Kakarlapudi Sirisha | Managing Director |
Everest Organics Similar Stocks
Pharmaids Pharmaceuticals Ltd.
32.00
-1.73 (5.13%)
Mercury Laboratories Ltd.
800.00
0.00 (0.00%)
Bal Pharma Ltd.
67.50
-0.69 (1.01%)
Bharat Immunologicals & Biologicals Corporation Ltd.
16.28
-0.64 (3.78%)
Star Imaging and Path Lab Ltd.
56.95
0.96 (1.71%)
Fortis Malar Hospitals Ltd.
50.50
-0.29 (0.57%)
Concord Drugs Ltd.
71.40
-0.23 (0.32%)
Godavari Drugs Ltd.
80.50
-1.98 (2.40%)
Makers Laboratories Ltd.
155.60
2.10 (1.37%)
Everest Organics FAQs
